A case of Posterior Reversible Encephalopathy Syndrome (PRES) associated with Gilenya® (Fingolimod) treatment for Multiple Sclerosis (MS).

A case of Posterior Reversible Encephalopathy Syndrome (PRES) associated with Gilenya® (Fingolimod) treatment for Multiple Sclerosis (MS).

We describe Posterior Reversible Encephalopathy Syndrome (PRES) in a woman with Multiple Sclerosis (MS) treated with Gilenya® (Fingolimod). The first symptoms appeared after 21 months of fingolimod treatment. She experienced headache, altered mental status, cognitive deficits, seizures and visual di...

Full description

Bibliographic Details
Main Authors:	Hans eLindå, Anders eVon Heijne
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-03-01
Series:	Frontiers in Neurology
Subjects:	MS fingolimod Posterior Reversible Encephalopathy Syndrome Gilenya PRES
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00039/full

Similar Items

Posterior Reversible Encephalopathy Syndrome (Pres) – A Case Report
by: Melis Türker, et al.
Published: (2011-12-01)

Posterior Reversible Encephalopathy Syndrome (PRES) in Rheumatic Autoimmune Disease
by: Izzat Khanjar, et al.
Published: (2018-03-01)

Posterior reversible encephalopathy syndrome on COVID-19
by: Sidharta Suwanto, MD, et al.
Published: (2022-09-01)

Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging
by: Redmond-Craig Anderson, et al.
Published: (2020-06-01)

ACUTE HYDROCEPHALUS AND POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN POSTPARTUM PERIOD: AN UNEXPECTED NEUROLOGICAL COMPLICATION
by: Aisha Khan Jadoon, et al.
Published: (2020-06-01)

MRI imaging of posterior reversible encephalopathy syndrome associated with pregnancy
by: Noha Mohamed AbdelMaboud Ibrahim, et al.
Published: (2014-06-01)

Fingolimod Augments Monomethylfumarate Killing of GBM Cells
by: Paul Dent, et al.
Published: (2020-01-01)

A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19
by: Małgorzata Cisowska-Adamiak, et al.
Published: (2022-07-01)

Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells
by: Paul Dent, et al.
Published: (2020-04-01)

Posterior reversible encephalopathy syndrome – Case report
by: Marcin Kulczyński, et al.
Published: (2020-10-01)

An atypical subacute presentation of posterior reversible encephalopathy syndrome
by: Eseosa Bazuaye-Ekwuyasi, et al.
Published: (2017-10-01)

A Case of Posterior Reversibl Encephalopathy Syndrome (PRES) During the Postpartum Period
by: Fatma Bayam, et al.
Published: (2007-08-01)

Posterior Reversible Encephalopathy Syndrome (PRES) After Acute Pancreatitis
by: Tara Murphy, et al.
Published: (2015-12-01)

Atypical presentation of cerebellar posterior reversible encephalopathy syndrome in a patient with HIV
by: Michael Raya, et al.
Published: (2020-02-01)

Imaging of Atypical and Complicated Posterior Reversible Encephalopathy Syndrome
by: Amin F. Saad, et al.
Published: (2019-09-01)

A broad spectrum of posterior reversible encephalopathy syndrome - a case series with clinical and paraclinical characterisation, and histopathological findings
by: Fatme Seval Ismail, et al.
Published: (2021-10-01)

Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients
by: Ali Önder Atça, et al.
Published: (2021-10-01)

Primary cutaneous cryptococcal infection due to fingolimod – Induced lymphopenia with literature review
by: Sachin M. Patil, et al.
Published: (2020-01-01)

Dengue-Associated Posterior Reversible Encephalopathy Syndrome, Vietnam
by: Nguyen Thi Hoang Mai, et al.
Published: (2018-02-01)

Posterior Reversible Encephalopathy Syndrome Unmasking Acute Glomerulonephritis
by: Sathish Kumar S., et al.
Published: (2014-01-01)

HOW DOES FINGOLIMOD (GILENYA®) FIT IN THE TREATMENT ALGORITHM FOR HIGHLY ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS?
by: Franz eFazekas, et al.
Published: (2013-05-01)

Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer’s Disease
by: Pablo Bascuñana, et al.
Published: (2023-02-01)

Fatal outcome of posterior reversible encephalopathy syndrome (PRES) in a lupus nephropathy patient: A case report
by: Ihssane Afilal, MD, et al.
Published: (2022-06-01)

Advanced Imaging Techniques in Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES)
by: Nasim Sheikh-Bahaei, et al.
Published: (2020-03-01)

A Case of Posterior Reversibl Encephalopathy Syndrome (PRES) Mimicking Encephalitis
by: Filiz KÜRKLÜ BOZKIR, et al.
Published: (2013-12-01)

Posterior reversible encephalopathy syndrome (PRES) associated with ovarian cancer and voltage-gated potassium channel antibodies: A case report
by: Laura K. Hadad, et al.
Published: (2017-05-01)

A 39 year-old woman with milk-alkali syndrome complicated by posterior reversible encephalopathy syndrome
by: Khiem Vu, et al.
Published: (2020-06-01)

Posterior reversible encephalopathy syndrome (PRES) and myeloma
by: Ricardos Ghanem, et al.
Published: (2024-01-01)

Posterior Reversible Encephalopathy Syndrome with Involvement of the Cervical Cord and Medulla: a Case Report
by: Xuan Hou, et al.
Published: (2015-01-01)

Posterior reversible encephalopathy syndrome in a known case of sickle-beta-thalassemia: a case presentation
by: Mumbaikar Kausha, et al.
Published: (2022-03-01)

Posterior reversible encephalopathy syndrome case report in an untreated, normotensive, ovarian cancer patient in the presence of paraneoplastic antibodies
by: Elad Barber, et al.
Published: (2020-09-01)

Posterior reversible encephalopathy syndrome (PRES): Should more attention be paid to the atypical forms?
by: Hajar Andour, MD, et al.
Published: (2023-02-01)

Posterior Reversible Encephalopathy Syndrome during Recovery from Hypovolemic Acute Kidney Injury after Trauma; Case Report and Literature Review
by: Richa Aggarwal, et al.
Published: (2017-07-01)

Rapid development of seizures and PRES in a COVID-19 patient
by: Fabiane Santos de Lima, et al.
Published: (2021-01-01)

Spectrum of Imaging Findings in Posterior Reversible Encephalopathy Syndrome (PRES) from Typical to Atypical
by: Jeel Y Patel, et al.
Published: (2022-06-01)

Mepolizumab-Induced Posterior Reversible Encephalopathy Syndrome (PRES), a new patient report
by: Vikram V. Puram, et al.
Published: (2022-08-01)

Cerebral perfusion in posterior reversible encephalopathy syndrome measured with arterial spin labeling MRI
by: Soudabeh Fazeli, et al.
Published: (2022-01-01)

Posterior reversible encephalopathy syndrome (PRES), an acute neurological syndrome due to reversible multifactorial brain edema: a case report
by: Camilla Cicognani, et al.
Published: (2013-04-01)

Severe pre-eclamptic women with headache: is posterior reversible encephalopathy syndrome an associated concurrent finding?
by: An-Shine Chao, et al.
Published: (2020-06-01)

Atypical posterior reversible encephalopathy syndrome in a case of thrombotic thrombocytopenic purpura with Sjogren's syndrome
by: Rahul Hegde, MD FRCR, et al.
Published: (2021-06-01)